These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19401155

  • 1. Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signaling.
    Lin J, Ding L, Jin R, Zhang H, Cheng L, Qin X, Chai J, Ye Q.
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1613-8. PubMed ID: 19401155
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of the human NRIP1/RIP140 gene by estrogen is modulated by dioxin signalling.
    Augereau P, Badia E, Fuentes M, Rabenoelina F, Corniou M, Derocq D, Balaguer P, Cavailles V.
    Mol Pharmacol; 2006 Apr; 69(4):1338-46. PubMed ID: 16391242
    [Abstract] [Full Text] [Related]

  • 3. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
    Zhou Z, Lu J, Dou J, Lv Z, Qin X, Lin J.
    Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
    [Abstract] [Full Text] [Related]

  • 4. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
    Ding L, Niu C, Zheng Y, Xiong Z, Liu Y, Lin J, Sun H, Huang K, Yang W, Li X, Ye Q.
    J Cell Mol Med; 2011 Jan; 15(1):72-85. PubMed ID: 19840196
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of loss of Fhl1 expression in human gastric cancer.
    Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M.
    Ann Surg Oncol; 2008 Aug; 15(8):2293-300. PubMed ID: 18465173
    [Abstract] [Full Text] [Related]

  • 6. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
    Docquier A, Garcia A, Savatier J, Boulahtouf A, Bonnet S, Bellet V, Busson M, Margeat E, Jalaguier S, Royer C, Balaguer P, Cavaillès V.
    Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
    [Abstract] [Full Text] [Related]

  • 7. Four and a half LIM protein 1: a partner for KCNA5 in human atrium.
    Yang Z, Browning CF, Hallaq H, Yermalitskaya L, Esker J, Hall MR, Link AJ, Ham AJ, McGrath MJ, Mitchell CA, Murray KT.
    Cardiovasc Res; 2008 Jun 01; 78(3):449-57. PubMed ID: 18281375
    [Abstract] [Full Text] [Related]

  • 8. Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells.
    Xiong Z, Ding L, Sun J, Cao J, Lin J, Lu Z, Liu Y, Huang C, Ye Q.
    IUBMB Life; 2010 Sep 01; 62(9):669-76. PubMed ID: 20734429
    [Abstract] [Full Text] [Related]

  • 9. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y, Jia Z, Nagele RG, Ichikawa H, Goldberg GS.
    Cancer Res; 2006 Feb 01; 66(3):1543-52. PubMed ID: 16452211
    [Abstract] [Full Text] [Related]

  • 10. Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acid.
    White KA, Yore MM, Deng D, Spinella MJ.
    J Biol Chem; 2005 Mar 04; 280(9):7829-35. PubMed ID: 15632153
    [Abstract] [Full Text] [Related]

  • 11. Receptor interacting protein 140 as a thyroid hormone-dependent, negative co-regulator for the induction of cellular retinoic acid binding protein I gene.
    Wei LN, Hu X.
    Mol Cell Endocrinol; 2004 Apr 15; 218(1-2):39-48. PubMed ID: 15130509
    [Abstract] [Full Text] [Related]

  • 12. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens.
    Miller H, Poon S, Hibbert B, Rayner K, Chen YX, O'Brien ER.
    Arterioscler Thromb Vasc Biol; 2005 Mar 15; 25(3):e10-4. PubMed ID: 15662019
    [Abstract] [Full Text] [Related]

  • 13. Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.
    Lukash T, Agback T, Dominguez F, Shiliaev N, Meshram C, Frolova EI, Agback P, Frolov I.
    J Virol; 2020 Dec 09; 95(1):. PubMed ID: 33055253
    [Abstract] [Full Text] [Related]

  • 14. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).
    Shalaby S, Hayashi YK, Goto K, Ogawa M, Nonaka I, Noguchi S, Nishino I.
    Neuromuscul Disord; 2008 Dec 09; 18(12):959-61. PubMed ID: 18952429
    [Abstract] [Full Text] [Related]

  • 15. Lipid-protein interactions of growth factor receptor-bound protein 14 in insulin receptor signaling.
    Rajala RV, Chan MD, Rajala A.
    Biochemistry; 2005 Nov 29; 44(47):15461-71. PubMed ID: 16300394
    [Abstract] [Full Text] [Related]

  • 16. Interaction of estrogen receptor-alpha ligand binding domain with nuclear proteins of aging mouse brain.
    Ghosh S, Thakur MK.
    J Neurosci Res; 2009 Aug 15; 87(11):2591-600. PubMed ID: 19326447
    [Abstract] [Full Text] [Related]

  • 17. Estrogen enhances activity of Wnt signaling during osteogenesis by inducing Fhl1 expression.
    Wu SM, Shih LH, Lee JY, Shen YJ, Lee HH.
    J Cell Biochem; 2015 Jul 15; 116(7):1419-30. PubMed ID: 25676585
    [Abstract] [Full Text] [Related]

  • 18. Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation.
    Guerrero-Santoro J, Yang L, Stallcup MR, DeFranco DB.
    J Cell Biochem; 2004 Jul 01; 92(4):810-9. PubMed ID: 15211577
    [Abstract] [Full Text] [Related]

  • 19. Identification of FHOD1-binding proteins and mechanisms of FHOD1-regulated actin dynamics.
    Westendorf JJ, Koka S.
    J Cell Biochem; 2004 May 01; 92(1):29-41. PubMed ID: 15095401
    [Abstract] [Full Text] [Related]

  • 20. Polyamine-modulated factor 1 represses glucocorticoid receptor activity.
    Shoji Y, Osman W, Zilliacus J.
    Biochem Biophys Res Commun; 2007 Sep 14; 361(1):176-81. PubMed ID: 17637456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.